NeoGenomics, Inc. Payments to Acquire Interest in Subsidiaries and Affiliates
NeoGenomics, Inc. (NEO) reported Payments to Acquire Interest in Subsidiaries and Affiliates of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates · last filed 2023-02-24
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2021-12-31 was $0.00.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2020-12-31 was $0.00.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2020-09-30 was $12.46M.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for fiscal 2022 was $0.00.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for fiscal 2020 was $25.60M.
- NeoGenomics, Inc. payments to acquire interest in subsidiaries and affiliates for fiscal 2019 was $0.00.
| Period end | Payments to Acquire Interest in Subsidiaries and Affiliates 3 month | Payments to Acquire Interest in Subsidiaries and Affiliates 6 month | Payments to Acquire Interest in Subsidiaries and Affiliates 9 month | Payments to Acquire Interest in Subsidiaries and Affiliates 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-24 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $0.00 derived: sum of 2 quarters · filed 2023-02-24 | $0.00 10-K · filed 2023-02-24 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $12.46M derived: sum of 2 quarters · filed 2023-02-24 | $25.60M 10-K · filed 2023-02-24 | |
| 2020-09-30 | $12.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $25.60M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $13.14M 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-31 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |